Thursday, November 12, 2026

USD/CNH Is 1% Down In The Last 10 Sessions

ViaNews Editorial Team

February 13, 2024

USD/CNH Is 1% Down In The Last 10 Sessions

(VIANEWS) - USD/CNH (USDCNH) has been up by 1.36% for the last 10 sessions. At 17:11 EST on Tuesday, 13 February, USD/CNH (USDCNH) is $7.23.

USD/CNH's yearly highs and lows, it's 0.251% up from its 52-week low and 0.043% down from its 52-week high.

News about

  • Eur/usd analysis: warning of oversold levels - 12 February 2024. According to DailyForex on Monday, 12 February, "According to the performance on the daily chart above, the general trend of the EUR/USD pair is still bearish, and as we mentioned before, moving below the psychological support level of 1.0800 will support the bears to move further downward. "
  • Eur/usd advances to one-week top on softer usd, upside potential seems limited. According to FXStreet on Monday, 12 February, "The EUR/USD pair loses traction following an early uptick to the 1.0800 mark, or over a one-week high on Monday and drops to a fresh daily low during the first half of the European session. ", "Apart from this, the underlying bullish sentiment across the global equity markets turns out to be another factor capping gains for the safe-haven buck and acts as a tailwind for the EUR/USD pair. "
  • Eur/usd weekly forecast: choppy results as angst and trading questions grow - 11 February 2024. According to DailyForex on Sunday, 11 February, "The EUR/USD has struggled lower since early this year, but its price action does correlate to other major currency pairs. ", "While questions mount about the European Central Bank's inability to move without the seemingly needed approval of other central banks and Germany's economic struggles, EUR/USD traders also have their eyes of U."
  • Eur/usd price analysis: could test psychological barrier at 1.0800 ahead of 14-day EMA. According to FXStreet on Monday, 12 February, "Given these conflicting signals, market participants may opt to await further confirmation of the directional trend for the EUR/USD pair before making trading decisions.", "A firm break above the EMA could intensify upward momentum for the EUR/USD pair, targeting the 23.6% Fibonacci retracement level at 1.0821, along with the significant barrier at 1.0850. "
  • Eur/usd forex signal: bullish rise from $1.0725 double bottom - 12 February 2024. According to DailyForex on Monday, 12 February, "My previous EUR/USD signal on 5thFebruarywas not triggered as the bullish price action unfortunately took place just below the support level which I had identified at $1.0726.", "In my previous analysis ofthe EUR/USD currency pairone week ago, I wrote that the technical picture had become notably more bearish, with the price chart showing that the price was moving down within a wide but symmetrical descendingprice channel. "

More news about USD/CNH (USDCNH).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,565 source documents archived
Query this data → isubstrate.com